Literature DB >> 22355035

Stereoselective interaction of pantoprazole with ABCG2. II. In vitro flux analysis.

Lipeng Wang1, Markos Leggas, Philip E Empey, Patrick J McNamara.   

Abstract

(-)Pantoprazole [(-)PAN] accumulated in rat milk stereoselectively, and this accumulation was attributed to rat Abcg2 (rAbcg2). In contrast, flux experiments at 25 μM showed that (+)pantoprazole [(+)PAN] was preferentially transported by rAbcg2. The purpose of the current study was to comprehensively evaluate the transport of PAN isomers in empty-Madin-Darby canine kidney II (MDCKII) and MDCKII cells expressing the human/rat (ABCG2/rAbcg2) isoforms at concentrations ranging from 3 to 200 μM. The apical-to-basolateral and basolateral-to-apical directional flux and the asymmetry efflux ratios were virtually identical for both isomers in empty (mock transfected)-MDCKII monolayers but were concentration dependent for both isomers in ABCG2 (human/rat)-MDCKII. Kinetic analysis using predicted cellular concentrations showed that (-)PAN had an 8-fold lower K(M) compared with (+)PAN for both rAbcg2 (0.25 versus 1.85 μM) and ABCG2 (0.6 versus 5.32 μM). (+)PAN had a 3-fold higher T(Max) compared with the (-)PAN for both rAbcg2 (7.86 versus 2.49 nmol/h · cm(2)) and ABCG2 (10.2 versus 3.29 nmol/h · cm(2)). Effective ABCG2 surface-area permeability of (-)PAN was 9920 and 5480 (μl/h)/cm(2) for rAbcg2 and ABCG2, respectively, compared with the (+)PAN isomer (4250 and 1920 μl/h · cm(2), respectively). These results indicate a stereoselective interaction of PAN with similar kinetic parameters for both human and rat ABCG2. (-)PAN is a better substrate than (+)PAN for ABCG2/rAbcg2 and provide a rationale for the preferential accumulation of (-)PAN into rat milk.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22355035      PMCID: PMC3336798          DOI: 10.1124/dmd.111.041616

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  21 in total

1.  Utility of 96 well Caco-2 cell system for increased throughput of P-gp screening in drug discovery.

Authors:  Praveen V Balimane; Karishma Patel; Anthony Marino; Saeho Chong
Journal:  Eur J Pharm Biopharm       Date:  2004-07       Impact factor: 5.571

2.  Stereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor, in extensive and poor metabolizers of S-mephenytoin.

Authors:  M Tanaka; T Ohkubo; K Otani; A Suzuki; S Kaneko; K Sugawara; Y Ryokawa; T Ishizaki
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

3.  Stereoselective interaction of pantoprazole with ABCG2. I. Drug accumulation in rat milk.

Authors:  Lipeng Wang; Patrick J McNamara
Journal:  Drug Metab Dispos       Date:  2012-02-16       Impact factor: 3.922

4.  Active transport of nitrofurantoin into rat milk.

Authors:  C Y Oo; E W Paxton; P J McNamara
Journal:  Adv Exp Med Biol       Date:  2001       Impact factor: 2.622

5.  The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk.

Authors:  Johan W Jonker; Gracia Merino; Sandra Musters; Antonius E van Herwaarden; Ellen Bolscher; Els Wagenaar; Elly Mesman; Trevor C Dale; Alfred H Schinkel
Journal:  Nat Med       Date:  2005-01-30       Impact factor: 53.440

6.  Excretion of pantoprazole in human breast.

Authors:  Lauren Plante; Geraldine M Ferron; Mary Unruh; Philip R Mayer
Journal:  J Reprod Med       Date:  2004-10       Impact factor: 0.142

7.  Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2).

Authors:  Gracia Merino; Johan W Jonker; Els Wagenaar; Mivis M Pulido; Antonio J Molina; Ana I Alvarez; Alfred H Schinkel
Journal:  Drug Metab Dispos       Date:  2005-02-09       Impact factor: 3.922

8.  Active transport of cimetidine and ranitidine into the milk of Sprague Dawley rats.

Authors:  P J McNamara; J A Meece; E Paxton
Journal:  J Pharmacol Exp Ther       Date:  1996-06       Impact factor: 4.030

9.  Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions.

Authors:  Pauline Breedveld; Noam Zelcer; Dick Pluim; Ozgür Sönmezer; Matthijs M Tibben; Jos H Beijnen; Alfred H Schinkel; Olaf van Tellingen; Piet Borst; Jan H M Schellens
Journal:  Cancer Res       Date:  2004-08-15       Impact factor: 12.701

10.  Active transport of cimetidine into human milk.

Authors:  C Y Oo; R J Kuhn; N Desai; P J McNamara
Journal:  Clin Pharmacol Ther       Date:  1995-11       Impact factor: 6.875

View more
  3 in total

1.  The effect of breast cancer resistance protein, multidrug resistant protein 1, and organic anion-transporting polypeptide 1B3 on the antitumor efficacy of the lipophilic camptothecin 7-t-butyldimethylsilyl-10-hydroxycamptothecin (AR-67) in vitro.

Authors:  Eleftheria Tsakalozou; Eyob D Adane; Kuei-Ling Kuo; Abigail Daily; Jeffrey A Moscow; Markos Leggas
Journal:  Drug Metab Dispos       Date:  2013-04-25       Impact factor: 3.922

Review 2.  PharmGKB summary: very important pharmacogene information for ABCG2.

Authors:  Alison E Fohner; Deanna J Brackman; Kathleen M Giacomini; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2017-11       Impact factor: 2.089

Review 3.  Enantioselective Drug Recognition by Drug Transporters.

Authors:  Yuichi Uwai
Journal:  Molecules       Date:  2018-11-22       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.